𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact

✍ Scribed by Alì, G; Boldrini, L; Lucchi, M; Picchi, A; Dell'Omodarme, M; Prati, M C; Mussi, A; Corsi, V; Fontanini, G

Book ID
110000249
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
457 KB
Volume
101
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intrapleural administration of interleuk
Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma : A Phase II study
✍ Philippe Astoul; Diane Picat-Joossen; Jean-Regis Viallat; Christian Boutin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 3 views

## Background: The prognosis associated with malignant pleural mesothelioma (mpm) is poor in spite of surgery, radiotherapy, photodynamic therapy, or chemotherapy. therefore, new therapeutic strategies, including intrapleural immunotherapy, are being investigated. several clinical studies have demo

Intrapleural administration of interleuk
Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma : A Phase II study
✍ Theodore G. Karrison; Nicholas J. Vogelzang 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

## Stage I Renal Cell Carcinoma I read the report by Kinouchi et al., 1 in which they concluded that the tumor grading of renal cell carcinoma was not predictive of the survival of Robson Stage I patients. This does not mean that the three-grading system is worthless; the authors simply showed tha